about
sameAs
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskUnsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival.A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential.Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSNo Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.A novel germline PALB2 deletion in Polish breast and ovarian cancer patientsGenome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerConsortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.Identification of six new susceptibility loci for invasive epithelial ovarian cancer.The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues.Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskCis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerShared genetics underlying epidemiological association between endometriosis and ovarian cancer.Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskThe putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerEvaluating the ovarian cancer gonadotropin hypothesis: a candidate gene studyIdentification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeAdult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization studyGeographical variations in TP53 mutational spectrum in ovarian carcinomas.Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
P50
Q24633316-5D9E543A-03C4-4BA5-9084-0069FB3A949FQ26799669-FC3EDE24-F3F3-40A6-BD62-7AC89D1F5CDAQ27320720-34EFEDA9-0703-439E-A77A-E2EE67EC9A90Q27824814-23892AE7-6C34-420D-B48E-0D186AA3BBCBQ28388497-51CBEA02-1006-45D6-BAD7-6A5D8FA55066Q28584533-38FC48AF-EDCB-404B-971F-E6363889C0B0Q30275832-0AE1819B-B1D7-4D1F-A452-0BC51CD4E2CCQ30276986-A89D9F1F-EC1B-4631-87BF-443FC93A3E3DQ30374367-55B305F2-1351-4D53-B213-FB47AD9E36EFQ33528298-36A39AD5-6922-4F19-AD2D-FC2C1AA574D1Q33778612-060AA746-E696-432C-A607-FCE2CB9214A0Q33847791-24470C5F-5855-422B-ABCC-60853E2C314AQ34342248-D01B0B53-0783-4154-AF0F-A288F68863F6Q35195271-19CA79B0-48A0-4293-A662-CDB1DE89068BQ35541663-ADA16180-7304-4765-911E-74D35B3C8B50Q35632884-C7123081-A606-4D66-A419-F743A62858D4Q35668946-1541DE75-8CE6-4EEE-8077-06C2258343ABQ35782435-7FA3271B-B8F6-4054-AA1C-2291E0C0BBAEQ36089391-46ADB7B4-EE1E-4216-A168-ABE416DC7AD2Q36124728-E997ECF8-757A-402E-A119-73F125F2A58EQ36218993-B2CAF399-FFFA-4FB0-92D7-8018D314F922Q36487146-24267827-9EFD-458C-9469-554EAFAA176FQ36685531-FA237CA0-4EAB-4861-B60B-162A337F0968Q36831854-6829C38E-B9F7-415B-B0C9-AD50C0DF65B1Q36897003-912F8412-C732-410F-8D19-5FB30758B8FBQ36956156-8EFCC992-E958-444B-8004-DE73F5C098F6Q36966218-9AD11BBB-FCEC-44C5-AB8E-C4017270FC5AQ37006170-281D45FF-F3DF-497C-AA7B-5E8C425E4425Q37589242-2A486E58-6EF5-4787-82E9-5F5F736185B8Q37624504-F4BF451A-6EBB-46E6-BD22-B15C47C66CFEQ37684409-9A31CD3C-4B1C-4873-9972-A0CC1D2445C1Q37684424-EA88556A-B998-49BD-9106-E5CE5A0BE9ECQ37687176-45CDA842-F2CD-4269-9842-3ECCF143E717Q37725393-976DE8FF-877F-43FD-88EA-2A573A8E7BFCQ38406780-76CBFA54-3A41-4A55-8468-14E4D74F40AFQ38720533-CA91A45B-7D4F-4FFF-BE87-3FE3848CDDC0Q39423088-117E2890-D778-45AC-95B2-8062EB23D84DQ42595284-1864F3E2-7A73-42A9-B365-4D21807FBCABQ43627377-6EDA63E2-02A3-4839-BD33-63F0DDD06EC6Q52647897-67E52DED-956C-4C08-9FC7-BF4FFFE06BCF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Agnieszka Dansonka-Mieszkowska
@ast
Agnieszka Dansonka-Mieszkowska
@en
Agnieszka Dansonka-Mieszkowska
@es
Agnieszka Dansonka-Mieszkowska
@nl
type
label
Agnieszka Dansonka-Mieszkowska
@ast
Agnieszka Dansonka-Mieszkowska
@en
Agnieszka Dansonka-Mieszkowska
@es
Agnieszka Dansonka-Mieszkowska
@nl
prefLabel
Agnieszka Dansonka-Mieszkowska
@ast
Agnieszka Dansonka-Mieszkowska
@en
Agnieszka Dansonka-Mieszkowska
@es
Agnieszka Dansonka-Mieszkowska
@nl
P106
P1153
57202315063
P21
P31
P496
0000-0002-2482-6523